SCHEMBL28992132

SCHEMBL28992132

COc1ccc2nc(-c3ccncc3)ccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.57
PDGFRA P16234 2/20 0.57
MAOA P21397 1/20 0.56
MAOB P27338 1/20 0.56
NPC1 O15118 4/20 0.55
RAB9A P51151 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 1/20 0.55
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
NCF1 P14598 1/20 0.54
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
AR P10275 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
NQO1 P15559 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30228533 1.00 PDGFRB (0.57) PDGFRBPDGFRAMAOAMAOBNPC1
SCHEMBL4486496 0.88 KDM4E (0.70) MAOAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL30228475 0.85 KDM4E (0.66) MAOAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL5682765 0.85 KDM4E (0.66) MAOAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL14500755 0.84 NPC1 (0.59) MAOAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL30228591 0.83 NPC1 (0.58) MAOAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL5547120 0.83 NPC1 (0.54) MAOAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL21282172 0.82 NPC1 (0.61) PDGFRBPDGFRANPC1RAB9ASMN1; SMN2
SCHEMBL2162844 0.81 APP (0.57) MAOAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL3012991 0.81 MAP4K4 (0.57) PDGFRBPDGFRANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109988106-B Amine compound for inhibiting SSAO/VAP-1 and application thereof in medicine 广东东阳光药业有限公司 2023-03-31 CN disclosed